<SEC-DOCUMENT>0001437749-25-012540.txt : 20250421
<SEC-HEADER>0001437749-25-012540.hdr.sgml : 20250421
<ACCEPTANCE-DATETIME>20250421163746
ACCESSION NUMBER:		0001437749-25-012540
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250415
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250421
DATE AS OF CHANGE:		20250421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASSAVA SCIENCES INC
		CENTRAL INDEX KEY:			0001069530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911911336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41905
		FILM NUMBER:		25853830

	BUSINESS ADDRESS:	
		STREET 1:		6801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		BUILDING 1; SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731
		BUSINESS PHONE:		512-501-2444

	MAIL ADDRESS:	
		STREET 1:		6801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		BUILDING 1; SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PAIN THERAPEUTICS INC
		DATE OF NAME CHANGE:	20000309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sava20250418_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:sava="http://www.sava.com/20250415"><head>
	<title>sava20250418_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 4/21/2025 7:28:00 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-335">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-336">0001069530</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="sava-20250415.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-15</xbrli:startDate>
<xbrli:endDate>2025-04-15</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 3pt auto 3pt auto;"/>
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-346">8-K</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 3pt auto 3pt auto;"/>
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section</b>&#160;<b>13 or 15(d) of the</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-347">April 15, 2025</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 3pt auto 3pt auto;"/>
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family:Times New Roman;font-size:24pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-348">Cassava Sciences, Inc.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Exact name of registrant as specified in its charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 3pt auto 3pt auto;"/>
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-349">Delaware</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-350">001-41905</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-351">91-1911336 </ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(State or other jurisdiction</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of incorporation)</b></div>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Commission</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>File Number)</b></div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(I.R.S. Employer</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Identification Number)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-352">6801 N Capital of Texas Highway, Building 1</ix:nonNumeric>; <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine2" id="ixv-353">Suite 300</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-354">Austin</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-355">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-356">78731</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Address of principal executive offices, including zip code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-357">512</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-358">501-2444</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Registrant</b>&#8217;<b>s telephone number, including area code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Former name or former address, if changed since last report.)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 3pt auto 3pt auto;"/>
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-359">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-360">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-361">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-362">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Title of each class</b></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Trading</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Symbol(s)</b></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-363">Common Stock</ix:nonNumeric>, $0.001 par value</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-364">SAVA</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-365">Nasdaq</ix:nonNumeric>&#160;Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-366">&#9744;</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; margin: 0pt;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 5.02.</b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Departure of Certain Executives</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On April 15, 2025, James W. Kupiec, M.D. informed Cassava Sciences, Inc. (the &#8220;Company&#8221;) of his intent to retire and tendered his resignation as the Company&#8217;s Chief Medical Officer, effective as of May 9, 2025.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Appointment of Principal Operating Officer and Amendment and Restatement of Certain Executive Employment Agreements</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On April 18, 2025, the Company and each of R. Christopher Cook and Eric J. Schoen (each, a &#8220;Covered Executive&#8221;) entered into an amendment and restatement of such Covered Executive&#8217;s existing employment agreement (each, an &#8220;Amended and Restated Employment Agreement&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On April 18, 2025, Mr. Cook, previously our Senior Vice President and General Counsel, was appointed Chief Operating and Legal Officer of the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Cook, 61, served as Senior Vice President and General Counsel since October 2022. He previously served, since 2017, as the Global Head of Litigation and Government Investigations for Alcon, a publicly traded medical device and pharmaceutical company, and before that as the Vice President and division General Counsel for Walmart Central America in San Jose, Costa Rica. Mr. Cook also spent seventeen years at Jones Day, where he was a litigation partner in the firm&#8217;s Washington, DC and Chicago offices. Mr. Cook served as an Assistant United States Attorney in Chicago. Mr. Cook earned his BA in English from Emory University and his JD from Harvard Law School.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">There are no arrangements or understandings between Mr. Cook and any other persons pursuant to which Mr. Cook&#8217;s appointment as Chief Operating and Legal Officer was made. Mr. Cook has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Amended and Restated Employment Agreement for Mr. Cook provides for, among other things, a base salary initially set at $475,000, an increase from his previous base salary of $438,000,&#160;and an annual bonus at target of 40% of base salary.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Amended and Restated Employment Agreement for Mr. Schoen provides for, among other things, a base salary that was not changed from his previous base salary and initially set at level effective as of January 1, 2024, as described in the Company&#8217;s definitive proxy statement for its 2024 annual meeting, and an annual bonus at target of 40% of base salary.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to each Amended and Restated Employment Agreement, if the Covered Executive is terminated without cause or resigns for good reason, he will be entitled to (i) continued payment of his base salary as then in effect through the effective date of his termination from employment, (ii) continued payment of his base salary as then in effect for a period of twelve (12) months following the date of termination and (iii) continued employment benefits through the Company&#8217;s medical plan, with premiums paid by the Company, until the earlier of twelve (12) months after termination or the time that he becomes covered under another employer-sponsored medical plan. The foregoing termination benefits are conditioned upon the Covered Executive signing and not revoking an employment separation and release agreement in a form acceptable to the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Except as otherwise specified above, the Amended and Restated Employment Agreements affirm and restate the preexisting terms of employment for each of the Covered Executives and includes other customary covenants, terms and conditions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The above description of the Amended and Restated Employment Agreements does not purport to be complete and is qualified in its entirety by reference to the text of the respective Amended and Restated Employment Agreements attached hereto as Exhibits 10.2 and 10.3.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Item 7.01. </b></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Regulation FD Disclosure.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On April 21, 2025, the Company issued a press release with respect to certain matters discussed in Item 5.02. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The information furnished in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall such information be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Item 9.01. </b></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:3.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline;">Exhibit </span></b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline;">No.</span></b></div>
			</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline;">Description</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>
			</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2*</div>
			</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_803688.htm" style="-sec-extract:exhibit;">Amended and Restated Employment Agreement between Cassava Sciences, Inc. and R. Christopher Cook</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.3*</div>
			</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_803689.htm" style="-sec-extract:exhibit;">Amended and Restated Employment Agreement between Cassava Sciences, Inc. and Eric J. Schoen</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.7%;">99.1</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;"><a href="ex_804586.htm" style="-sec-extract:exhibit;">Press Release issued by Cassava Sciences, Inc. dated April 21, 2025</a></td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:middle;width:1.1%;">&#160;</td>
			<td style="vertical-align:middle;width:48.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">* Management contract, compensatory plan or arrangement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES </b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>CASSAVA SCIENCES, INC.</b></div>
			</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">a Delaware corporation</div>
			</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Date: April 21, 2025</div>
			</td>
			<td style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">By:</div>
			</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">/s/ &#160;Eric J. Schoen</div>
			</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Eric J. Schoen</div>
			</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Chief Financial Officer</div>
			</td>
			<td style="vertical-align: top; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="margin: 0pt;">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ex_803688.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_803688.htm</title>

	<!-- Generated by ThunderDome Portal - 4/18/2025 5:40:41 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 10.2</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the &#8220;Agreement&#8221;) is made this 18<sup style="vertical-align:top;line-height:120%;">th</sup> day of April 2025 (the &#8220;Effective Date&#8221;), by and between CASSAVA SCIENCES, INC., 6801 N. Capital of Texas Highway, Building 1, Suite 300, Austin, TX 78731 (&#8220;Cassava&#8221; or &#8220;Company&#8221;), and ROBERT CHRISTOPHER COOK, an individual (&#8220;Cook&#8221; or &#8220;Executive&#8221;). This Agreement amends and restates in its entirety the agreement between the Parties dated October 12, 2022, governing the terms of employment of Executive by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>1.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Position and Duties</u></b><b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Position</u>. Executive shall continue to serve as the Chief Operational and Legal Officer of Cassava reporting to the President and Chief Executive Officer and shall perform the usual and customary duties of Chief Operational and Legal Officer under the direction of the President and Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Duties</u>. As Chief Operational and Legal Officer, Executive will be primarily responsible for overseeing day-to-day operations of the Company and leading the Company&#8217;s legal function. Examples of such duties include: (i) supporting the CEO in the development and execution of the Company&#8217;s strategic mission; (ii) facilitating cross-functional collaboration; (iii) leading the legal function of the Company; (iv) providing legal counsel and guidance to the Company and its management on a variety of legal and policy matters; (iii) developing legal strategies and solutions; (v) ensuring regulatory compliance; (vi) mitigating and managing risk; (vii) reviewing contracts, policies, procedures, regulations, bylaws and other legal documents; (viii) managing outside counsel; (ix) providing strategic and tactical guidance on matters related to the Company&#8217;s affairs; (x) maintaining professional growth and development to keep abreast of latest developments in legal areas; and (xi) performing such other duties as the President and Chief Executive Officer shall assign Executive from time to time. Executive agrees to devote Executive&#8217;s full business time and best efforts, business judgment, skill, and knowledge exclusively to the advancement of the business and interests of the Company and to the discharge of Executive&#8217;s duties and responsibilities; <i>provided, however</i>, that Executive may serve on outside boards (with prior written notice to and written approval by the Chief Executive Officer), participate in charitable and civic organizations, and manage personal investments to the extent such activities do not interfere with the performance of Executive&#8217;s duties and responsibilities to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>2.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Compensation and Benefits</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Base Salary</u>. The Company will pay Executive as compensation for Executive&#8217;s services a base salary at the annualized rate of Four Hundred Seventy-Five Thousand Dollars and No Cents ($475,000.00) (&#8220;Base Salary&#8221;), paid semi-monthly. Base Salary is subject to customary payroll deductions and withholdings authorized or required by applicable law. Executive&#8217;s Base Salary will be subject to review and adjustment from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Bonuses</u>. Executive will be eligible to receive an annual bonus (target bonus amount will be forty percent (40%) of Base Salary) based upon performance-related criteria to be established by the Company, and subject to establishment of a Bonus Plan by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Options</u>. From time to time, the Company may grant, in its sole discretion, stock options or other types of equity-based compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">d.&nbsp;&nbsp;&nbsp;&nbsp;<u>Benefits</u>. Executive will be eligible to participate in the employee benefit plans maintained by the Company applicable to other key executives of the Company, including (without limitation) retirement plans, savings or profit-sharing plans, deferred compensation plans, supplemental retirement or excess benefit plans, disability, health, accident and other insurance programs, and similar plans or programs, subject in each case to the generally applicable terms and conditions of the plan or program in question and to the determination of any committee administering such plan or program.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">e.&nbsp;&nbsp;&nbsp;&nbsp;<u>Paid Time Off</u>. As an Officer of Cassava Sciences, Executive will not accrue, and the Company will not record, any specific amount of vacation or paid time off. The ability to take paid time off is not intended to be a form of additional wages for services performed. Instead, Executive may utilize paid time off as Executive&#8217;s work responsibilities allow.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">f.&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses</u>. The Company will reimburse Executive for all reasonable business, entertainment, and travel expenses actually incurred or paid by the Executive in the performance of Executive&#8217;s services on behalf of the Company, in accordance with the Company&#8217;s expense reimbursement policy in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>3.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Term of Employment</u>.</b> Executive&#8217;s continued employment pursuant to this Agreement will commence on the Effective Date and continue indefinitely unless and until terminated in accordance with paragraph 4 of this Agreement. During the Term, the Company reserves the right to make personnel decisions regarding Executive&#8217;s employment, including but not limited to, promotions, salary adjustment, changes to scope of responsibilities, transfer and termination consistent with the Company&#8217;s needs, subject to the provisions of paragraph 4(c)(ii) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>4.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination of Employment</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Death</u>. Executive&#8217;s employment with the Company will terminate automatically upon the death of the Executive. In such event, the Company shall pay to Executive&#8217;s beneficiaries or Executive&#8217;s estate, as the case may be, any accrued Base Salary and any unreimbursed business expenses incurred by Executive in connection with Executive&#8217;s duties through the date of Executive&#8217;s death. Nothing in this paragraph shall affect any entitlement of the Executive&#8217;s heirs to the benefits of any life insurance provided by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Disability</u>. If Executive is unable to perform Executive&#8217;s duties for a period of sixty (60) consecutive days as a result of any physical or mental impairment, then, to the extent permitted by law, the Company may terminate this Agreement on or after the sixtieth (60th) day of Executive&#8217;s inability to perform Executive&#8217;s job duties. In such event, the Company will pay Base Salary to Executive until such time as Executive shall become entitled to receive disability benefit under the long-term disability insurance policy maintained by the Company (but not more than ninety (90) days following termination of employment), but no other compensation or reimbursement of any kind, including without limitation, severance compensation. Nothing in this paragraph shall affect Executive&#8217;s rights to benefits under any disability plan in which Executive is a participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Voluntary Resignation without Good Reason or Termination By Company for Cause</u>. If Executive&#8217;s employment with the Company terminates due to Executive&#8217;s voluntary resignation without Good Reason (as defined below), or if the Company involuntarily terminates Executive&#8217;s employment for Cause (as defined below), the Company will pay Executive all accrued Base Salary though the termination date but no other compensation or reimbursement of any kind, including without limitation, severance compensation. If Executive resigns from employment with the Company without Good Reason, Executive agrees to provide a minimum of thirty (30) days&#8217; advance notice of such resignation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, Termination for &#8220;Cause&#8221; means: (a) any intentional action or intentional failure to act that was performed in bad faith and to the detriment of the Company; (b) any intentional refusal or intentional failure to act in accordance with any lawful and proper directive or order of the Board; (c) willful and habitual neglect of the duties assigned by the Board; (d) any action or omission that materially and negatively affects the business and/or reputation of the Company; (e) violation of any federal, state or local laws in connection with the performance of Executive&#8217;s job duties (including without limitation laws prohibiting employment discrimination and workplace harassment), or (f) any conviction for, or plea of guilty or <i>nolo contendere</i> to, a felony or misdemeanor involving moral turpitude under any applicable federal, state or local law; <i>provided, however,</i> that, in the event that any of the foregoing Cause events is capable of being cured, the Company will provide written notice to Executive describing the nature of such Cause event, and Executive will have five (5) business days to cure such event.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#8220;Good Reason&#8221; means the occurrence of any of the following events without the Executive's prior consent: (a) material reduction in Executive's Base Salary; (b) any relocation of Executive's reporting location by more than 100 miles of Austin, Texas; (c) material breach by the Company of any provision of this Agreement; (d) material, adverse change in Executive's duties or responsibilities (other than temporarily while Executive is physically or mentally disabled or as required by applicable law); or (e) material adverse change in the management reporting structure applicable to Executive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">d.&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination By Company Without Cause or Resignation by Executive for Good Reason</u>. If Executive&#8217;s employment with the Company is involuntarily terminated for any reason other than Cause or if Executive resigns from Executive&#8217;s position for Good Reason, Executive will be entitled to receive: (i) Base Salary through the effective date of Executive&#8217;s termination from employment (the &#8220;Termination Date&#8221;); (ii) severance compensation equal to Executive&#8217;s Base Salary, immediately prior to the Termination Date, for twelve (12) months after the date of termination; (iii) continued participation in the Company medical plan, at the Company&#8217;s expense, until the earlier of (a) the date Executive becomes covered under another employer-sponsored medical plan, or (b) twelve (12) months after the Termination Date. Payment of the separation benefits outlined in this paragraph 4(d) is expressly conditioned on Executive&#8217;s entering into and not revoking an employment separation and release agreement in a form acceptable to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">e.&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duty to Mitigate</u>. The Executive shall not be required to mitigate the amount of any payment contemplated by paragraph 4(d) (whether by seeking new employment or in any other manner).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">f.&nbsp;&nbsp;&nbsp;&nbsp;<u>Change in Control</u>. In the event Executive&#8217;s employment with Company is terminated without Cause after a Change in Control (as defined herein), Executive will be paid Executive&#8217;s regular base salary, and will continue to receive employment benefits, for a period of twelve (12) months following Executive&#8217;s last date of employment with the Company; <i>provided, however,</i> that Executive signs and does not revoke an employment separation and release agreement acceptable to the Company. For purposes of this Agreement, a &#8220;Change in Control&#8221; means the occurrence of one or more of the following four events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Any one person or more than one person acting as a &#8220;group&#8221; (within the meaning of Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), becomes the beneficial owner (as such term is defined in Rule 13d-3 promulgated under the Exchange Act) of equity securities of the Company that, together with equity securities previously held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the outstanding equity securities of the Company; <i>provided, however</i>, if any one person or more than one person acting as a &#8220;group&#8221;, is considered to own more than 50% of the total fair market value or total voting power of the equity securities of the Company, the acquisition of additional equity securities by the same person or group will not be considered a Change-in-Control. Acquisitions of equity securities of the Company through the issuance of equity securities by the Company in capital raising transactions by the Company shall not constitute a Change-in-Control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;A sale of all or substantially all the assets of the Company to a non-affiliate third party, <i>provided, however</i>, that any sale of all or substantially all assets of the Company to an entity shall not constitute a Change in Control if the holders of the voting securities of the Company outstanding immediately prior to such transaction hold securities which represent, immediately after such transaction, more than 50% of the combined voting power of the voting securities of such entity (or the parent of such entity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iii.&nbsp;&nbsp;&nbsp;&nbsp;Within six (6) months after a merger, consolidation or liquidation involving the Company or a contested election of a Company director, the individuals who were directors of the Company immediately prior thereto shall cease to constitute a majority of the board of directors of the surviving entity (or the parent of such entity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iv.&nbsp;&nbsp;&nbsp;&nbsp;Within six (6) months after the consummation of a tender offer or exchange offer for voting securities of the Company, the individuals who were directors of the Company immediately prior to the commencement thereof shall cease to constitute a majority of the board of directors of the surviving entity (or the parent of such entity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">g.&nbsp;&nbsp;&nbsp;&nbsp;<u>409A Compliance</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, no severance or other benefits payable upon termination from employment pursuant to this Agreement, when considered together with any other payments or benefits that are considered deferred compensation (together, the &#8220;Deferred Payments&#8221;) under Section 409A, will be payable until the Executive has a &#8220;separation from service&#8221; within the meaning of Section 409A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, if the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of Executive&#8217;s termination from employment, then, if required, the Deferred Payments, which are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s termination from employment will accrue, to the extent required, during such six (6) month period and will become payable in a lump sum payment on the date six (6) months and one day following the date of Executive&#8217;s termination of employment or the date of the Executive&#8217;s death, if earlier. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iii.&nbsp;&nbsp;&nbsp;&nbsp;The foregoing provision is intended to comply with the requirements of Section 409A so that none of the payments and benefits to be provided under this Agreement will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>5.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification</u></b>. Subject to and in accordance with the terms of the existing Indemnification Agreement between the Parties, in the event that Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil, criminal, administrative, or investigative (a &#8220;Proceeding&#8221;), other than any Proceeding initiated by the Executive or the Company related to any contest or dispute between the Executive and the Company or any of its affiliates with respect to this Agreement or the Executive's employment, by reason of the fact that the Executive is or was a director or officer of the Company, or any affiliate of the Company, Executive shall be indemnified and held harmless by the Company to the fullest extent applicable to any other officer or director of the Company/to the maximum extent permitted under applicable law and the Company's bylaws from and against any liabilities, costs, claims, and expenses, including all costs and expenses incurred in defense of any Proceeding (including attorneys' fees).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>6.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidential Information</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidentiality Agreement</u>. At all times during the term of Executive&#8217;s employment and thereafter, Executive shall hold in strictest confidence and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Company, any Confidential Information or trade secrets belonging to the Company. As a condition of employment, Executive has entered into a Confidential Information and Invention Assignment Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Defend Trade Secrets Act, 28 U.S.C. &#167; 1833, Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is: (i) made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or (ii) made in a complaint or other document filed in a lawsuit or other proceeding if such a filing is made under seal. Executive further understands that any individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to Executive&#8217;s attorney and use the trade secret information in the court proceeding so long as the individual: (i) files any document containing the trade secret under seal, and (ii) does not disclose the trade secret, except pursuant to court order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement prevents Executive from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Former Employer Information</u>. During Executive&#8217;s employment with the Company, Executive will not improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that Executive will not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Third Party Information</u>. Executive recognizes that the Company has received and, in the future, will receive from third parties their confidential or proprietary information subject to a duty on the Company&#8217;s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Executive agrees to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out Executive&#8217;s work for the Company consistent with the Company&#8217;s agreement with such third party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>7.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Dispute Resolution</u></b>. Executive will attempt in good faith to resolve any dispute with the Company through discussion, evaluation, negotiation and conciliation. If any dispute arising out or relating to this Agreement, or the interpretation, application or enforcement of its terms, or any other dispute arising out of relating to Executive&#8217;s employment with the Company (including, without limitation, statutory or common law employment claims but excluding claims not subject to arbitration under Section 402 of the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021, 9 U.S.C. &#167; 402), such dispute(s) will be resolved by final and binding arbitration in accordance with the then existing Employment Arbitration Rules of the American Arbitration Association (&#8220;AAA&#8221;). This arbitration provision constitutes a waiver by the Parties of any right to a jury trial and relates to the resolution of all claims arising out of, relating to, or in connection with this Agreement, the interpretation, validity, construction, performance, breach or termination of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;The Parties will agree upon one arbitrator, who shall be an individual skilled in the legal and business aspects of the subject matter of this Agreement and of the dispute. If the Parties cannot agree upon one arbitrator, an arbitrator shall be selected by the Parties through the arbitrator selection procedures established by the AAA. The arbitration proceedings shall take place in Austin, Texas or such other location as the Parties may agree upon. The arbitration proceedings (including any pre-hearing depositions and written discovery responses) will be completely confidential and only the Parties and their authorized representatives, legal counsel and witnesses will be permitted to attend the arbitration hearing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;In rendering an award, the arbitrator shall determine the rights and obligations of the Parties according to the substantive law of the State of Texas (or federal law, where applicable) without regard to any principles governing conflicts of laws and the arbitrator&#8217;s decision shall be governed by state and federal substantive law, as though the matter were before a court of law. Such decision shall be final, conclusive and binding on the Parties to the arbitration. The decision of the arbitrator shall be made within thirty (30) days following the close of the hearing. The Parties agree that the award shall be enforceable exclusively by any state or federal court of competent jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;If any part of this arbitration procedure is in conflict with any mandatory requirement or applicable law, the law shall govern, and that part of this arbitration procedure shall be reformed and construed to the maximum extent possible in conformance with the applicable law. The arbitration procedure shall remain otherwise unaffected and enforceable. The Parties agree that any Party shall be entitled to commence legal action in any court of competent jurisdiction to compel any other Party to this Agreement to submit any claim or controversy covered by this paragraph 7 to mandatory and binding arbitration in accordance with the terms and provisions outlined herein and/or for preliminary injunctive relief to preserve the <i>status quo</i> or to prevent any potential or on-going violation of this Agreement pending the outcome of arbitration proceedings under this paragraph.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>8.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law and Consent to Jurisdiction</u>.</b> This Agreement shall be deemed to have been made and delivered in the State of Texas, where Executive&#8217;s services will be performed, in whole or in part, and shall be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of Texas and controlling federal law without giving effect to any conflicts of laws provisions. Further, to the extent that any Party is required to initiate legal action to enforce any right or obligation under this Agreement (including arbitration under paragraph 7), the Parties agree that any such litigation shall be filed in the United States District Court for the Western District of Texas or the District Court of Travis County, Texas, and both Parties consent to the exclusive personal jurisdiction of such courts.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>9.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignment</u>.</b> This Agreement, and the rights and obligations of Executive under this Agreement, may not be assigned by Executive without the express written consent of the Company. The rights and obligations of the Company under this Agreement shall be binding upon, and inure to the benefit of, the Company, its successors and assigns. However, this Agreement will be enforceable by and as to the Company and its successors and assigns. Further, in the event of a change in ownership of Cassava, the Company will have the right to assign all rights and obligations under this Agreement to any successor owner without Executive&#8217;s consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>10.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>.</b> All notices, requests, demands, claims and other communications that are required to be, or which may be, given under this Agreement shall be in writing and (a) delivered in person or by courier; (b) sent by e-mail, telecopy or facsimile transmission; or (c) mailed, certified first class mail, postage prepaid, return receipt requested, to the Parties at the following addresses:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;If to COMPANY:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">CASSAVA SCIENCES, INC.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Attn: Eric Schoen</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Chief Financial Officer</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">6801 N. Capital of Texas Highway</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Building 1, Suite 300</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Austin, TX 78731</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">eschoen@cassavasciences.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;If to EXECUTIVE:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Robert Christopher Cook<br>
XXX<br>
XXX<br>
ccook@cassavasciences.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">or to such other address as the Party to whom notice is being given shall have furnished to the other Party. Such notices shall be effective (i) if delivered in person or by courier, upon actual receipt by the intended recipient, (ii) if sent by e-mail, telecopy or facsimile transmission, when the sender receives confirmation that such notice was received at the e-mail address or telecopier number of the addressee, or (iii) if mailed, upon the earlier of five (5) business days after deposit in the mail or the date of delivery as shown by the return receipt. Any notice delivered in person, by courier, or by mail shall also be sent via email to the address listed above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>11.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Attorneys</u></b><u>&#8217;</u><b><u> Fees</u></b><b>. </b>In the event that either Party initiates legal action in any court or adjudicative body to enforce any provision of this Agreement, or initiates legal action based upon the breach of any provision of this Agreement by any other Party, or submits any dispute to arbitration under paragraph 7 of this Agreement, each party shall bear its own fees and expenses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>12.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Waivers</u>.</b> No claim arising out of a breach of this Agreement can be discharged, in whole or in part, by a waiver of that claim, unless such waiver is in writing and executed by the Party against whom the waiver is asserted. Any waiver by either Party of a breach of any provision of this Agreement by the other Party shall not be construed as a continuing waiver, or as a waiver of any breach of another provision of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>13.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>.</b> In the event that any provision of this Agreement shall be deemed to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>14.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Captions</u>. </b>The captions of the paragraphs and provisions of this Agreement are for convenience only and shall not affect in any way the meaning or interpretation of this Agreement or any of its provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>15.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>.</b> The Parties acknowledge and agree that this Agreement, together with the Release, constitute the entire agreement between the Parties; that the Parties have executed this Agreement based upon the terms set forth herein; that the Parties have not relied on any prior agreement or representation, whether oral or written, which is not set forth in this Agreement; that no prior agreement, whether oral or written, shall have any effect on the terms and provisions of this Agreement; and that, except as otherwise provided in this Agreement, all prior agreements pertaining to the subject matter of this Agreement, whether oral or written, are expressly superseded and/or revoked by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>16.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment</u>.</b> The Parties further agree that the provisions of this Agreement may not be modified by any subsequent agreement unless the modifying agreement is: (i) in writing; (ii) specifically references this Agreement; (iii) signed by Executive; and (iv) signed and approved by an authorized representative of Cassava.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>IN WITNESS WHEREOF</i>, the Parties hereto have executed this Agreement as of the date first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">CASSAVA SCIENCES, INC.</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">By:</td>
			<td style="padding-left: 18pt; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 46%;">/s/ RICHARD J. BARRY&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 46%;">Richard J. Barry<br>
			President and Chief Executive Officer</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">ROBERT CHRISTOPHER COOK</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 46%; border-bottom: 1px solid rgb(0, 0, 0);">/s/ R. CHRISTOPHER COOK</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>ex_803689.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html><head>
	<title>ex_803689.htm</title>

	<!-- Generated by ThunderDome Portal - 4/18/2025 5:45:43 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 10.3</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the &#8220;Agreement&#8221;) is made this 18<sup style="vertical-align:top;line-height:120%;">th</sup> day of April 2025 (the &#8220;Effective Date&#8221;), by and between CASSAVA SCIENCES, INC., 6801 N. Capital of Texas Highway, Building 1, Suite 300, Austin, TX 78731 (&#8220;Cassava&#8221; or &#8220;Company&#8221;), and ERIC SCHOEN, an individual (&#8220;Schoen&#8221; or &#8220;Executive&#8221;). This Agreement amends and restates in its entirety the agreement between the Parties dated October 8, 2018, and as subsequently amended, governing the terms of employment of Executive by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>1.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Position and Duties</u></b><b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Position</u>. Executive shall continue to serve as the Chief Financial Officer of Cassava reporting to the President and Chief Executive Officer and shall perform the usual and customary duties of Chief Financial Officer under the direction of the President and Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Duties</u>. As Chief Financial Officer, Executive will be primarily responsible for leading the Company&#8217;s financial function. Examples of such duties include: (i) leading the finance and accounting functions of the Company; (ii) providing strategic and tactical direction on all matters related to Company affairs; (iii) acting as a primary interface between the Company and its investors; (iv) managing the relationship with the Company&#8217;s accountants; (v) traveling as needed to meet with investors and other stakeholders; and (vi) performing such other duties as the President and Chief Executive Officer shall assign Executive from time to time. Executive agrees to devote Executive&#8217;s full business time and best efforts, business judgment, skill, and knowledge exclusively to the advancement of the business and interests of the Company and to the discharge of Executive&#8217;s duties and responsibilities; <i>provided, however</i>, that Executive may serve on outside boards (with prior written notice to and written approval by the Chief Executive Officer), participate in charitable and civic organizations, and manage personal investments to the extent such activities do not interfere with the performance of Executive&#8217;s duties and responsibilities to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>2.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Compensation and Benefits</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Base Salary</u>. The Company will pay Executive as compensation for Executive&#8217;s services a base salary at the annualized rate of Four Hundred Seventy-Five Thousand Dollars and No Cents ($475,000.00) (&#8220;Base Salary&#8221;), paid semi-monthly. Base Salary is subject to customary payroll deductions and withholdings authorized or required by applicable law. Executive&#8217;s Base Salary will be subject to review and adjustment from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Bonuses</u>. Executive will be eligible to receive an annual bonus (target bonus amount will be forty percent (40%) of Base Salary) based upon performance-related criteria to be established by the Company, and subject to establishment of a Bonus Plan by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Options</u>. From time to time, the Company may grant, in its sole discretion, stock options or other types of equity-based compensation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">d.&nbsp;&nbsp;&nbsp;&nbsp;<u>Benefits</u>. Executive will be eligible to participate in the employee benefit plans maintained by the Company applicable to other key executives of the Company, including (without limitation) retirement plans, savings or profit-sharing plans, deferred compensation plans, supplemental retirement or excess benefit plans, disability, health, accident and other insurance programs, and similar plans or programs, subject in each case to the generally applicable terms and conditions of the plan or program in question and to the determination of any committee administering such plan or program.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">e.&nbsp;&nbsp;&nbsp;&nbsp;<u>Paid Time Off</u>. As an Officer of Cassava Sciences, Executive will not accrue, and the Company will not record, any specific amount of vacation or paid time off. The ability to take paid time off is not intended to be a form of additional wages for services performed. Instead, Executive may utilize paid time off as Executive&#8217;s work responsibilities allow.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">f.&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses</u>. The Company will reimburse Executive for all reasonable business, entertainment, and travel expenses actually incurred or paid by the Executive in the performance of Executive&#8217;s services on behalf of the Company, in accordance with the Company&#8217;s expense reimbursement policy in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>3.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Term of Employment</u>.</b> Executive&#8217;s continued employment pursuant to this Agreement will commence on the Effective Date and continue indefinitely unless and until terminated in accordance with paragraph 4 of this Agreement. During the Term, the Company reserves the right to make personnel decisions regarding Executive&#8217;s employment, including but not limited to, promotions, salary adjustment, changes to scope of responsibilities, transfer and termination consistent with the Company&#8217;s needs, subject to the provisions of paragraph 4(c)(ii) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>4.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination of Employment</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Death</u>. Executive&#8217;s employment with the Company will terminate automatically upon the death of the Executive. In such event, the Company shall pay to Executive&#8217;s beneficiaries or Executive&#8217;s estate, as the case may be, any accrued Base Salary and any unreimbursed business expenses incurred by Executive in connection with Executive&#8217;s duties through the date of Executive&#8217;s death. Nothing in this paragraph shall affect any entitlement of the Executive&#8217;s heirs to the benefits of any life insurance provided by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Disability</u>. If Executive is unable to perform Executive&#8217;s duties for a period of sixty (60) consecutive days as a result of any physical or mental impairment, then, to the extent permitted by law, the Company may terminate this Agreement on or after the sixtieth (60th) day of Executive&#8217;s inability to perform Executive&#8217;s job duties. In such event, the Company will pay Base Salary to Executive until such time as Executive shall become entitled to receive disability benefit under the long-term disability insurance policy maintained by the Company (but not more than ninety (90) days following termination of employment), but no other compensation or reimbursement of any kind, including without limitation, severance compensation. Nothing in this paragraph shall affect Executive&#8217;s rights to benefits under any disability plan in which Executive is a participant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Voluntary Resignation without Good Reason or Termination By Company for Cause</u>. If Executive&#8217;s employment with the Company terminates due to Executive&#8217;s voluntary resignation without Good Reason (as defined below), or if the Company involuntarily terminates Executive&#8217;s employment for Cause (as defined below), the Company will pay Executive all accrued Base Salary though the termination date but no other compensation or reimbursement of any kind, including without limitation, severance compensation. If Executive resigns from employment with the Company without Good Reason, Executive agrees to provide a minimum of thirty (30) days&#8217; advance notice of such resignation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, Termination for &#8220;Cause&#8221; means: (a) any intentional action or intentional failure to act that was performed in bad faith and to the detriment of the Company; (b) any intentional refusal or intentional failure to act in accordance with any lawful and proper directive or order of the Board; (c) willful and habitual neglect of the duties assigned by the Board; (d) any action or omission that materially and negatively affects the business and/or reputation of the Company; (e) violation of any federal, state or local laws in connection with the performance of Executive&#8217;s job duties (including without limitation laws prohibiting employment discrimination and workplace harassment), or (f) any conviction for, or plea of guilty or <i>nolo contendere</i> to, a felony or misdemeanor involving moral turpitude under any applicable federal, state or local law; <i>provided, however,</i> that, in the event that any of the foregoing Cause events is capable of being cured, the Company will provide written notice to Executive describing the nature of such Cause event, and Executive will have five (5) business days to cure such event.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#8220;Good Reason&#8221; means the occurrence of any of the following events without the Executive's prior consent: (a) material reduction in Executive's Base Salary; (b) any relocation of Executive's reporting location by more than 100 miles of Austin, Texas; (c) material breach by the Company of any provision of this Agreement; (d) material, adverse change in Executive's duties or responsibilities (other than temporarily while Executive is physically or mentally disabled or as required by applicable law); or (e) material adverse change in the management reporting structure applicable to Executive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">d.&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination By Company Without Cause or Resignation by Executive for Good Reason</u>. If Executive&#8217;s employment with the Company is involuntarily terminated for any reason other than Cause or if Executive resigns from Executive&#8217;s position for Good Reason, Executive will be entitled to receive: (i) Base Salary through the effective date of Executive&#8217;s termination from employment (the &#8220;Termination Date&#8221;); (ii) severance compensation equal to Executive&#8217;s Base Salary, immediately prior to the Termination Date, for twelve (12) months after the date of termination; (iii) continued participation in the Company medical plan, at the Company&#8217;s expense, until the earlier of (a) the date Executive becomes covered under another employer-sponsored medical plan, or (b) twelve (12) months after the Termination Date. Payment of the separation benefits outlined in this paragraph 4(d) is expressly conditioned on Executive&#8217;s entering into and not revoking an employment separation and release agreement in a form acceptable to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">e.&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duty to Mitigate</u>. The Executive shall not be required to mitigate the amount of any payment contemplated by paragraph 4(d) (whether by seeking new employment or in any other manner).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">f.&nbsp;&nbsp;&nbsp;&nbsp;<u>Change in Control</u>. In the event Executive&#8217;s employment with Company is terminated without Cause after a Change in Control (as defined herein), Executive will be paid Executive&#8217;s regular base salary, and will continue to receive employment benefits, for a period of twelve (12) months following Executive&#8217;s last date of employment with the Company; <i>provided, however,</i> that Executive signs and does not revoke an employment separation and release agreement acceptable to the Company. For purposes of this Agreement, a &#8220;Change in Control&#8221; means the occurrence of one or more of the following four events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Any one person or more than one person acting as a &#8220;group&#8221; (within the meaning of Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), becomes the beneficial owner (as such term is defined in Rule 13d-3 promulgated under the Exchange Act) of equity securities of the Company that, together with equity securities previously held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the outstanding equity securities of the Company; <i>provided, however</i>, if any one person or more than one person acting as a &#8220;group&#8221;, is considered to own more than 50% of the total fair market value or total voting power of the equity securities of the Company, the acquisition of additional equity securities by the same person or group will not be considered a Change-in-Control. Acquisitions of equity securities of the Company through the issuance of equity securities by the Company in capital raising transactions by the Company shall not constitute a Change-in-Control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;A sale of all or substantially all the assets of the Company to a non-affiliate third party, <i>provided, however</i>, that any sale of all or substantially all assets of the Company to an entity shall not constitute a Change in Control if the holders of the voting securities of the Company outstanding immediately prior to such transaction hold securities which represent, immediately after such transaction, more than 50% of the combined voting power of the voting securities of such entity (or the parent of such entity).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iii.&nbsp;&nbsp;&nbsp;&nbsp;Within six (6) months after a merger, consolidation or liquidation involving the Company or a contested election of a Company director, the individuals who were directors of the Company immediately prior thereto shall cease to constitute a majority of the board of directors of the surviving entity (or the parent of such entity).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iv.&nbsp;&nbsp;&nbsp;&nbsp;Within six (6) months after the consummation of a tender offer or exchange offer for voting securities of the Company, the individuals who were directors of the Company immediately prior to the commencement thereof shall cease to constitute a majority of the board of directors of the surviving entity (or the parent of such entity).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">g.&nbsp;&nbsp;&nbsp;&nbsp;<u>409A Compliance</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, no severance or other benefits payable upon termination from employment pursuant to this Agreement, when considered together with any other payments or benefits that are considered deferred compensation (together, the &#8220;Deferred Payments&#8221;) under Section 409A, will be payable until the Executive has a &#8220;separation from service&#8221; within the meaning of Section 409A.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, if the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of Executive&#8217;s termination from employment, then, if required, the Deferred Payments, which are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s termination from employment will accrue, to the extent required, during such six (6) month period and will become payable in a lump sum payment on the date six (6) months and one day following the date of Executive&#8217;s termination of employment or the date of the Executive&#8217;s death, if earlier. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">iii.&nbsp;&nbsp;&nbsp;&nbsp;The foregoing provision is intended to comply with the requirements of Section 409A so that none of the payments and benefits to be provided under this Agreement will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>5.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification</u></b>. Subject to and in accordance with the terms of the existing Indemnification Agreement between the Parties, in the event that Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil, criminal, administrative, or investigative (a &#8220;Proceeding&#8221;), other than any Proceeding initiated by the Executive or the Company related to any contest or dispute between the Executive and the Company or any of its affiliates with respect to this Agreement or the Executive's employment, by reason of the fact that the Executive is or was a director or officer of the Company, or any affiliate of the Company, Executive shall be indemnified and held harmless by the Company to the fullest extent applicable to any other officer or director of the Company/to the maximum extent permitted under applicable law and the Company's bylaws from and against any liabilities, costs, claims, and expenses, including all costs and expenses incurred in defense of any Proceeding (including attorneys' fees).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>6.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidential Information</u>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidentiality Agreement</u>. At all times during the term of Executive&#8217;s employment and thereafter, Executive shall hold in strictest confidence and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Company, any Confidential Information or trade secrets belonging to the Company. As a condition of employment, Executive has entered into a Confidential Information and Invention Assignment Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">i.&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Defend Trade Secrets Act, 28 U.S.C. &#167; 1833, Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is: (i) made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or (ii) made in a complaint or other document filed in a lawsuit or other proceeding if such a filing is made under seal. Executive further understands that any individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to Executive&#8217;s attorney and use the trade secret information in the court proceeding so long as the individual: (i) files any document containing the trade secret under seal, and (ii) does not disclose the trade secret, except pursuant to court order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-indent: 18pt;">ii.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement prevents Executive from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Former Employer Information</u>. During Executive&#8217;s employment with the Company, Executive will not improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that Executive will not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Third Party Information</u>. Executive recognizes that the Company has received and, in the future, will receive from third parties their confidential or proprietary information subject to a duty on the Company&#8217;s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Executive agrees to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out Executive&#8217;s work for the Company consistent with the Company&#8217;s agreement with such third party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>7.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Dispute Resolution</u></b>. Executive will attempt in good faith to resolve any dispute with the Company through discussion, evaluation, negotiation and conciliation. If any dispute arising out or relating to this Agreement, or the interpretation, application or enforcement of its terms, or any other dispute arising out of relating to Executive&#8217;s employment with the Company (including, without limitation, statutory or common law employment claims but excluding claims not subject to arbitration under Section 402 of the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021, 9 U.S.C. &#167; 402), such dispute(s) will be resolved by final and binding arbitration in accordance with the then existing Employment Arbitration Rules of the American Arbitration Association (&#8220;AAA&#8221;). This arbitration provision constitutes a waiver by the Parties of any right to a jury trial and relates to the resolution of all claims arising out of, relating to, or in connection with this Agreement, the interpretation, validity, construction, performance, breach or termination of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;The Parties will agree upon one arbitrator, who shall be an individual skilled in the legal and business aspects of the subject matter of this Agreement and of the dispute. If the Parties cannot agree upon one arbitrator, an arbitrator shall be selected by the Parties through the arbitrator selection procedures established by the AAA. The arbitration proceedings shall take place in Austin, Texas or such other location as the Parties may agree upon. The arbitration proceedings (including any pre-hearing depositions and written discovery responses) will be completely confidential and only the Parties and their authorized representatives, legal counsel and witnesses will be permitted to attend the arbitration hearing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;In rendering an award, the arbitrator shall determine the rights and obligations of the Parties according to the substantive law of the State of Texas (or federal law, where applicable) without regard to any principles governing conflicts of laws and the arbitrator&#8217;s decision shall be governed by state and federal substantive law, as though the matter were before a court of law. Such decision shall be final, conclusive and binding on the Parties to the arbitration. The decision of the arbitrator shall be made within thirty (30) days following the close of the hearing. The Parties agree that the award shall be enforceable exclusively by any state or federal court of competent jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;If any part of this arbitration procedure is in conflict with any mandatory requirement or applicable law, the law shall govern, and that part of this arbitration procedure shall be reformed and construed to the maximum extent possible in conformance with the applicable law. The arbitration procedure shall remain otherwise unaffected and enforceable. The Parties agree that any Party shall be entitled to commence legal action in any court of competent jurisdiction to compel any other Party to this Agreement to submit any claim or controversy covered by this paragraph 7 to mandatory and binding arbitration in accordance with the terms and provisions outlined herein and/or for preliminary injunctive relief to preserve the <i>status quo</i> or to prevent any potential or on-going violation of this Agreement pending the outcome of arbitration proceedings under this paragraph.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>8.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law and Consent to Jurisdiction</u>.</b> This Agreement shall be deemed to have been made and delivered in the State of Texas, where Executive&#8217;s services will be performed, in whole or in part, and shall be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of Texas and controlling federal law without giving effect to any conflicts of laws provisions. Further, to the extent that any Party is required to initiate legal action to enforce any right or obligation under this Agreement (including arbitration under paragraph 7), the Parties agree that any such litigation shall be filed in the United States District Court for the Western District of Texas or the District Court of Travis County, Texas, and both Parties consent to the exclusive personal jurisdiction of such courts.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>9.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignment</u>.</b> This Agreement, and the rights and obligations of Executive under this Agreement, may not be assigned by Executive without the express written consent of the Company. The rights and obligations of the Company under this Agreement shall be binding upon, and inure to the benefit of, the Company, its successors and assigns. However, this Agreement will be enforceable by and as to the Company and its successors and assigns. Further, in the event of a change in ownership of Cassava, the Company will have the right to assign all rights and obligations under this Agreement to any successor owner without Executive&#8217;s consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>10.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>.</b> All notices, requests, demands, claims and other communications that are required to be, or which may be, given under this Agreement shall be in writing and (a) delivered in person or by courier; (b) sent by e-mail, telecopy or facsimile transmission; or (c) mailed, certified first class mail, postage prepaid, return receipt requested, to the Parties at the following addresses:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;If to COMPANY:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">CASSAVA SCIENCES, INC.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Attn: Christopher Cook</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">SVP and General Counsel</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">6801 N. Capital of Texas Highway</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Building 1, Suite 300</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Austin, TX 78731</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">ccook@cassavasciences.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 18pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;If to EXECUTIVE:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">Eric Schoen<br>
XXX<br>
XXX<br>
eschoen@cassavasciences.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">or to such other address as the Party to whom notice is being given shall have furnished to the other Party. Such notices shall be effective (i) if delivered in person or by courier, upon actual receipt by the intended recipient, (ii) if sent by e-mail, telecopy or facsimile transmission, when the sender receives confirmation that such notice was received at the e-mail address or telecopier number of the addressee, or (iii) if mailed, upon the earlier of five (5) business days after deposit in the mail or the date of delivery as shown by the return receipt. Any notice delivered in person, by courier, or by mail shall also be sent via email to the address listed above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>11.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Attorneys</u></b><u>&#8217;</u><b><u> Fees</u></b><b>. </b>In the event that either Party initiates legal action in any court or adjudicative body to enforce any provision of this Agreement, or initiates legal action based upon the breach of any provision of this Agreement by any other Party, or submits any dispute to arbitration under paragraph 7 of this Agreement, each party shall bear its own fees and expenses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>12.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Waivers</u>.</b> No claim arising out of a breach of this Agreement can be discharged, in whole or in part, by a waiver of that claim, unless such waiver is in writing and executed by the Party against whom the waiver is asserted. Any waiver by either Party of a breach of any provision of this Agreement by the other Party shall not be construed as a continuing waiver, or as a waiver of any breach of another provision of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>13.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>.</b> In the event that any provision of this Agreement shall be deemed to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>14.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Captions</u>. </b>The captions of the paragraphs and provisions of this Agreement are for convenience only and shall not affect in any way the meaning or interpretation of this Agreement or any of its provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>15.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>.</b> The Parties acknowledge and agree that this Agreement, together with the Release, constitute the entire agreement between the Parties; that the Parties have executed this Agreement based upon the terms set forth herein; that the Parties have not relied on any prior agreement or representation, whether oral or written, which is not set forth in this Agreement; that no prior agreement, whether oral or written, shall have any effect on the terms and provisions of this Agreement; and that, except as otherwise provided in this Agreement, all prior agreements pertaining to the subject matter of this Agreement, whether oral or written, are expressly superseded and/or revoked by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>16.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment</u>.</b> The Parties further agree that the provisions of this Agreement may not be modified by any subsequent agreement unless the modifying agreement is: (i) in writing; (ii) specifically references this Agreement; (iii) signed by Executive; and (iv) signed and approved by an authorized representative of Cassava.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>IN WITNESS WHEREOF</i>, the Parties hereto have executed this Agreement as of the date first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">CASSAVA SCIENCES, INC.</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">By:</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">/s/ RICHARD J. BARRY&nbsp;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: middle; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard J. Barry<br>
			President and Chief Executive Officer</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">ERIC SCHOEN</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 46%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">/s/ ERIC SCHOEN</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex_804586.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_804586.htm</title>

	<!-- Generated by ThunderDome Portal - 4/21/2025 7:25:58 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 99.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="prlogo.jpg" src="prlogo.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>AUSTIN, TX, April 21, 2025</b> (<b>GLOBENEWSWIRE)</b> &#8211; Cassava Sciences, Inc. (NASDAQ: SAVA, &#8220;Cassava&#8221;, the &#8220;Company&#8221;), a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system (CNS) disorders such as tuberous sclerosis complex (TSC)-related epilepsy, today announced the retirement of James W. Kupiec, MD, Chief Medical Officer, effective May 9, 2025. The Company also appointed Jack Moore, PhD, as Senior Vice President, Clinical Development, reporting to Rick Barry, Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;The entire Cassava team is grateful for Jim&#8217;s service as our Chief Medical Officer. He is retiring after a notable career of exemplary work, with exceptional expertise in Alzheimer&#8217;s disease drug development. Thanks to Jim&#8217;s attention to patient care and his deep credibility in the scientific community, Cassava completed a high-quality clinical trial program in Alzheimer&#8217;s disease that was carried out with respect for the dignity of patients and their caregivers. We wish Jim a happy and fulfilling retirement,&#8221; said <b>Rick Barry, President and Chief Executive Officer</b> of Cassava.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dr. Moore joins Cassava as Senior Vice President, Clinical Development, effective April 28, 2025. He will be responsible for advancing the clinical evaluation of simufilam in new potential indications, including TSC. Dr. Moore will build on an established track record of working in leading global pharmaceutical companies to advance novel compounds for the treatment of CNS disorders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;As we formulate our strategy going forward, we are pleased to have Jack on board. He brings broad medical affairs and clinical development expertise, plus extensive experience working with study sites and patient advocacy groups. These skills will be invaluable to Cassava as we take the next steps in our TSC program, identify potential clinical collaborators and study sites, and explore additional potential applications,&#8221; commented <b>Mr.</b> <b>Barry</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;I am eager to contribute my clinical development expertise to Cassava&#8217;s emerging program for simufilam in TSC and other applications,&#8221; said <b>Dr. Jack Moore, SVP, Clinical Development</b> of Cassava.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About Jack Moore, PhD</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jack Moore is an accomplished biopharmaceutical executive with extensive drug development expertise in CNS and neurodegenerative diseases including Alzheimer&#8217;s disease, multiple sclerosis, amyotrophic lateral sclerosis, and other neuro-immunologic and oncologic disorders. He has a history of building and executing clinical development strategies and publication plans, as well as engaging with key opinion leaders, advisory boards, patient advocates, and medical communities in established and rare clinical indications across multiple drug modalities. Most recently, Dr. Moore was Vice President, Head of Global Medical Affairs at Alector Inc. Prior to that, Dr. Moore held clinical and medical affairs leadership roles of increasing responsibility at global pharmaceutical companies including Janssen Pharmaceutica, Novartis Pharmaceuticals Corporation, and Celgene Corporation, a subsidiary of Bristol-Myers Squibb Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dr. Moore earned his Doctor of Philosophy in Neuroscience at the University of North Texas, and he was a Post-Doctoral Research Fellow at the University of Texas at Southwestern Medical Center at Dallas. He earned his Master of Science in Physiology at the University of North Texas, and his Bachelor of Science in Biology at Texas State University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About</b>&nbsp;<b>Cassava Sciences, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cassava Sciences, Inc.&nbsp;(NASDAQ: SAVA), is a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system disorders such as tuberous sclerosis complex (TSC)-related epilepsy. Simufilam is a proprietary, investigational oral small molecule that targets the filamin A protein. The Company is based in&nbsp;Austin, Texas.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For more information, please visit:&nbsp;<u>https://www.CassavaSciences.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For More Information Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investors</b><br>
Sandya von der Weid<br>
<u>svonderweid@lifesciadvisors.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Media</b><br>
<u>media@cassavasciences.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Company</b><br>
Eric Schoen, Chief Financial Officer<br>
(512) 501-2450<br>
<u>ESchoen@CassavaSciences.com</u><br>
<u>IR@cassavasciences.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Cautionary Note Regarding Forward-Looking Statements:</i></b>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>This news release contains forward-looking statements that include but are not limited to statements regarding: our plans to conduct preclinical studies of simufilam relating to seizures in TSC, the potential for simufilam as a treatment for TSC-related epilepsy and other indications, the timing of anticipated milestones, and management retirees or appointments. These statements may be identified by words such as </i>&#8220;<i>anticipate</i>&#8221;<i>, </i>&#8220;<i>before,</i>&#8221;<i> </i>&#8220;<i>believe</i>&#8221;<i>, </i>&#8220;<i>could</i>&#8221;<i>, </i>&#8220;<i>expect</i>&#8221;<i>, </i>&#8220;<i>forecast</i>&#8221;<i>, </i>&#8220;<i>intend</i>&#8221;<i>, </i>&#8220;<i>may</i>&#8221;<i>, </i>&#8220;<i>pending,</i>&#8221;<i> </i>&#8220;<i>plan</i>&#8221;<i>, </i>&#8220;<i>possible</i>&#8221;<i>, </i>&#8220;<i>potential</i>&#8221;<i>, </i>&#8220;<i>prepares for,</i>&#8221;<i> </i>&#8220;<i>will</i>&#8221;<i>, and other words and terms of similar meaning.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Such statements are based on our current expectations and projections about future events. Such statements speak only as of the date of this news release and are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those risks relating to the ability to efficiently discontinue the Company</i>&#8217;<i>s Alzheimer</i>&#8217;<i>s disease development program, the ability to advance preclinical studies related to TSC-related epilepsy, and other risks inherent in drug discovery and development or specific to</i>&nbsp;<i>Cassava Sciences, Inc., as described in the section entitled </i>&#8220;<i>Risk Factors</i>&#8221;<i> in our Annual Report on Form 10-K for the year ended</i>&nbsp;<i>December 31, 2024, and future reports to be filed with the</i>&nbsp;<i>SEC.</i>&nbsp;<i>The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from expectations in any forward-looking statement.</i>&nbsp;<i>In light of these risks, uncertainties and assumptions, the forward-looking statements and events discussed in this news release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, we disclaim any intention or responsibility for updating or revising any forward-looking statements. For further information regarding these and other risks related to our business, investors should consult our filings with the</i>&nbsp;<i>SEC, which are available on the</i>&nbsp;<i>SEC</i>&#8217;<i>s</i>&nbsp;<i>website at</i>&nbsp;<u><i>www.sec.gov</i></u><i>.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>All of our pharmaceutical assets under development are investigational product candidates. They have not been approved for use in any medical indication by any regulatory authority in any jurisdiction and their safety, efficacy or other desirable attributes, if any, have not been established in any patient population. Consequently, none of our product candidates is approved or available for sale anywhere in the world.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Our clinical results from earlier-stage clinical trials may not be indicative of future results from later-stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements or any scientific data we present or publish.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>We are in the business of new drug discovery, development and commercialization. Our research and development activities are long, complex, costly and involve a high degree of risk. Holders of our common stock should carefully read our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q in their entirety, including the risk factors therein. Because risk is fundamental to the process of drug discovery, development and commercialization, you are cautioned to not invest in our publicly traded securities unless you are prepared to sustain a total loss of the money you have invested.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>###</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sava-20250415.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/21/2025 7:28:05 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:sava="http://www.sava.com/20250415" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sava.com/20250415">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sava-20250415_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sava-20250415_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sava-20250415_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.sava.com/20250415/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="sava_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>sava-20250415_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/21/2025 7:28:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.sava.com/20250415/role/statement-document-and-entity-information" xlink:href="sava-20250415.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.sava.com/20250415/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>sava-20250415_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/21/2025 7:28:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line Two</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>sava-20250415_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/21/2025 7:28:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.sava.com/20250415/role/statement-document-and-entity-information" xlink:href="sava-20250415.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.sava.com/20250415/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>prlogo.jpg
<TEXT>
begin 644 prlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH
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M6(!T*^%OVN_B:(X+7X8Z3< R7*P:GXH:-L[+;/F:=I<F.]PRB]GC.?W26Q8
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M7_!2?]K72OV(OV*OCO\ M"W=Q;KK_AGPC<:-\/+">7RWUKXF>+&7P]X&TR$
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MOP[X-\/Z/X"\"^+KH_VUXGU>ST73?[3O-<TO0K+3K);N]B>[NY)G$$"N^QV
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MWV;6_ EQ&J-]CMO#.D/=.)]10-_1N0""",@\$'H1Z&ODGX$_L(?LB?LQ^/\
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M3?+%HW_LJ.(Q6.KX[DK0Q,:-"C2A*I'V>&HM5.64H\DN:=9*I)1DXII*[/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">Cassava Sciences, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Apr. 15,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-41905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">91-1911336 <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">6801 N Capital of Texas Highway, Building 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity, Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">78731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">501-2444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SAVA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001069530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +:$E5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( +:$E5K"%U7P[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%*Q# 0AE]%<F^G3:M"Z.:B>%(07%"\A<GL
M;K!I0S+2[MO;UMTNH@_@,3-_OOD&IL&@L(_T'/M D1VEJ]&W75(8-N+ '!1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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MQ]0(LR/3=#_;$+6!:^ EMJD;'@3O]X+^&<%QIFX([5P1W_,[_^[N EL)Z)>
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M-@S>=9^+.!+IBE!D -2K'-S['T.8;V2MB>.:02X@TUN>AQ&>U!CZWP@GMLS
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" "VA)5:EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "VA)5:F5R<(Q &  "<)P  $P
M            @ 'A 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M +:$E5IVD"NU:00  &<1   8              " @2((  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "VA)5:GZ ;\+$"  #B#   #0
M            @ '!#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +:$E5J7
MBKL<P    !,"   +              "  9T/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( +:$E5HZJJ+G0 $  #P"   /              "  880  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " "VA)5:)!Z;HJT   #X 0  &@
M        @ 'S$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " "VA)5:99!YDAD!  #/ P  $P              @ '8$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   B%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sava20250418_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sava.com/20250415/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>sava-20250415.xsd</File>
    <File>sava-20250415_def.xml</File>
    <File>sava-20250415_lab.xml</File>
    <File>sava-20250415_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="sava20250418_8k.htm">sava20250418_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sava20250418_8k.htm": {
   "nsprefix": "sava",
   "nsuri": "http://www.sava.com/20250415",
   "dts": {
    "schema": {
     "local": [
      "sava-20250415.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sava-20250415_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sava-20250415_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sava-20250415_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "sava20250418_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 37,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.sava.com/20250415/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sava20250418_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sava20250418_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.sava.com/20250415/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001437749-25-012540-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-012540-xbrl.zip
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MZ*6#EZH=T")OU5NS\"C/I>E:>@/!C=!&)D,+C"^5VQD!.V6!H 1Z!>C<4N=
M$?J2E!^@!33B+2PIFD]HT_,+F0$+I^J00_BZ@2%2>\"WDL:A-3!@T3!MS76
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MH4W606@/=KX[HDWCHH>2>_4%K<N? 35>E36:VT%" T%S7'*@8:SR6"T"^)^
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M\\]!?W#&+ E4EJ(\"_2!\;_\V4*-2>3-P-\QA3XO/V@!@;@:H<_/:VMG*+)
MW2.]!KWP:<(VE<[!) :;3$NS_8_57Z*'P5\:!:<ZEXJ/E&S=V.2E>:+8B3-,
MXP?T0!16WAIG=)[B"^.FHA;H5P*6O2>!XL'"-9?H&1Q3-F?L?DS)E'A#;DA
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M+Q]=ZRJ(8DQE7#&*YU7!EV#Z.Z5NZVHM+Q)"U(&[2!73FJ,(:*!9K(57^P*
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M$P/.4(&TY4^=2D6)Q(9Z9(?H*78E*BVYZ4@Q=%P+6B#F4&?8+VY8*,I.(7@
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M% 80MD2N(=T%*RXT9GLCG5LU(I[<J*1BB6HA1T\P<FJ_)35#)[!=&PI!R4+
M#1:4I>=5SEX%;.*0^7P?G@+/(CU#[;9R=]MU)-XKFH3]@C0MYT!+1(6Q0<YR
M)1+I%![ 6=2-@K])MQ)+ZZX&8JE#AH>)*FNW5S>E@KD\)C1BDO^<*:C#M>+
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MGG#&B/^) -KP"0@#FS$K\/D5YG] ):'*@T=.H,3A?WP"Q+#9TV1\'I4XMX,
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M4$L! A0#%     @ MH256M1*?-DO*@  U]T   T              ( !YBH
M &5X7S@P,S8X.2YH=&U02P$"% ,4    " "VA)5:,!N"%@\0  #'/   #0
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M4$L! A0#%     @ MH256C27F!.#!   -2\  !4              ( !AW0
M '-A=F$M,C R-3 T,35?<')E+GAM;%!+ 0(4 Q0    ( +:$E5K=.HEK3A8
M )Z>   3              "  3UY  !S879A,C R-3 T,3A?.&LN:'1M4$L%
3!@     (  @ ^@$  +R/      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>sava20250418_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sava-20250415.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2025-04-15</startDate>
            <endDate>2025-04-15</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-335">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-336">0001069530</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-346">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-347">2025-04-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-348">Cassava Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-349">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-350">001-41905</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-351">91-1911336</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-352">6801 N Capital of Texas Highway, Building 1</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="d20258K" id="ixv-353">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-354">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-355">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-356">78731</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-357">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-358">501-2444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-359">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-360">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-361">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-362">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-363">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-364">SAVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-365">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-366">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
